首页> 外文OA文献 >AB0685 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with ankylosing spondylitis: long-term results from measure 1 and measure 2

【2h】

AB0685 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with ankylosing spondylitis: long-term results from measure 1 and measure 2

机译：AB0685 Secukinumab在强直性脊柱炎患者中提供了工作生产率和健康相关生活质量的持续改进：测量1的长期结果和2

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A Deodhar; PG Conaghan; V Strand; A Boonen; G Ferraccioli; F Van den Bosch; V Bhosekar; B Porter; K Gandhi; S Jugl;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week, Phase Ⅲ China-centric study, MEASURE 5 [J] . Feng Huang, Yi Wang, Hao-Min Qiu, 中华医学杂志（英文版） . 2020,第021期

机译：Secukinumab在强直性脊柱炎的体征和症状方面提供了显着且持续的改善：来自以中国为中心的Ⅲ期Ⅲ期研究（为期52周，测量结果5）
2. Secukinumab provides sustained improvements in the signs and symptoms of active ankylosing spondylitis with high retention rate: 3-year results from the phase III trial, MEASURE 2 [J] . Susanne Rohrer, Ricardo Blanco, Joachim Sieper, RMD Open . 2017,第2期

机译：Secukinumab可以持续改善活动性强直性脊柱炎的症状和体征，且保留率高：III期试验（措施2）的3年结果
3. SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS OF ACTIVE ANKYLOSING SPONDYLITIS: 2-YEAR RESULTS FROM A PHASE 3 TRIAL WITH SUBCUTANEOUS LOADING AND MAINTENANCE DOSING (MEASURE-2) [J] . Marzo-Ortega H., Legerton C. W., Sieper J., Clinical and experimental rheumatology . 2016,第4期

机译：SECUKINUMAB在主动性强直性脊柱炎的体征和症状中提供了持续的改善：来自第3阶段试验的两年结果，该试验具有连续的负荷和维持剂量（措施2）
4. No adverse physiological responses to infrared whole body hyperthermia in patients with rheumatoid arthritis and ankylosing spondylitis compared to healthy subjects. [C] . F.G.J. OOSTERVELD, E. KOOPMAN, J. OLDE SCHOLTENHUIS, Advances in biomedical research . 2010

机译：与健康受试者相比，类风湿性关节炎和强直性脊柱炎患者对红外全身热疗没有不利的生理反应。
5. A new tool to measure the relationship between health-related quality of life and workforce productivity. [D] . Huang, David T. 2008

机译：一种测量健康相关生活质量与劳动力生产率之间关系的新工具。
6. Secukinumab provided significant and sustained improvement in the signs and symptoms of ankylosing spondylitis: results from the 52-week Phase III China-centric study MEASURE 5 [O] . Feng Huang, Fei Sun, Wei-Guo Wan, 2020

机译：Secukinumab在强直性脊柱炎的迹象和症状提供了显着和持续改善：结果来自52周第三期中方的学习测量5
7. 50. Sustained Improvement in Health-Related Quality of Life, Work Productivity, Employability and Reduced Healthcare Resource Utilization of Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis Treated with Golimumab: 5-Year Results from Three Phase III Studies [O] . Chenglong Han, Arthur Kavanaugh, Mark C. Genovese, 2014

机译：50.持续改善有关的健康生活质量，工作生产力，就业性和减少患者的类风湿性关节炎，银屑病关节炎和脊椎动物脊髓炎的医疗资源利用率：三期III研究的5年结果

AB0685 Secukinumab provides sustained improvements in work productivity and health related quality of life in patients with ankylosing spondylitis: long-term results from measure 1 and measure 2

著录项

引文网络

相似文献

相关主题

期刊订阅